Homie Razavi joins World Hepatitis Alliance Executive Board

18 Mar 2016 Tara Farrell

We are delighted to announce that Homie A. Razavi, PhD, has joined the World Hepatitis Alliance (WHA) Executive Board as a Non-Executive member.

Homie, who is the founder and managing director at the Centre for Disease Analysis (CDA) in Louisville CO, USA, brings a wealth of knowledge and insight to WHA. CDA specialises in studying complex and poorly understood diseases. Its main goal is to study and publish data to help educate stakeholders and support decision-making in different countries.

Since 2008, he has led a team of epidemiologists and modellers to quantify epidemiology of HCV and HBV and forecast the future impact of these infections. They have analysed HCV disease burden in over seventy countries and have helped countries develop national strategies. You can find out more here.

He has a broad background, which includes basic research, commercial development, portfolio management, and decision analysis.  He is a fellow of the Society for Decision Professionals.

We look forward to working closely with Homie to help deliver the World Hepatitis Alliance strategic plan and to drive action towards elimination of viral hepatitis by 2030.